Patents by Inventor Yasuko Nakano

Yasuko Nakano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7435551
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: October 14, 2008
    Assignee: Fujirebio, Inc.
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara
  • Patent number: 7067634
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: June 27, 2006
    Assignee: Rebio Gen, Inc.
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi HIrose, Koichi Matsubara
  • Publication number: 20050266506
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Application
    Filed: June 22, 2005
    Publication date: December 1, 2005
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara
  • Publication number: 20050048565
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Application
    Filed: August 16, 2002
    Publication date: March 3, 2005
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara